[go: up one dir, main page]

AU2001238288A1 - Method and compositions for treating fibrotic diseases - Google Patents

Method and compositions for treating fibrotic diseases

Info

Publication number
AU2001238288A1
AU2001238288A1 AU2001238288A AU3828801A AU2001238288A1 AU 2001238288 A1 AU2001238288 A1 AU 2001238288A1 AU 2001238288 A AU2001238288 A AU 2001238288A AU 3828801 A AU3828801 A AU 3828801A AU 2001238288 A1 AU2001238288 A1 AU 2001238288A1
Authority
AU
Australia
Prior art keywords
compositions
fibrotic diseases
treating fibrotic
treating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001238288A
Other languages
English (en)
Inventor
Tadashi Kohyama
Steve I. Rennard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Medical Center UNMC
Original Assignee
University of Nebraska Medical Center UNMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Medical Center UNMC filed Critical University of Nebraska Medical Center UNMC
Publication of AU2001238288A1 publication Critical patent/AU2001238288A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001238288A 2000-02-16 2001-02-15 Method and compositions for treating fibrotic diseases Abandoned AU2001238288A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18287600P 2000-02-16 2000-02-16
US60182876 2000-02-16
US22762900P 2000-08-24 2000-08-24
US60227629 2000-08-24
PCT/US2001/004797 WO2001060358A1 (fr) 2000-02-16 2001-02-15 Procede et compositions permettant de traiter les maladies fibrosantes

Publications (1)

Publication Number Publication Date
AU2001238288A1 true AU2001238288A1 (en) 2001-08-27

Family

ID=26878513

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001238288A Abandoned AU2001238288A1 (en) 2000-02-16 2001-02-15 Method and compositions for treating fibrotic diseases

Country Status (4)

Country Link
EP (1) EP1261331A4 (fr)
JP (1) JP2004502643A (fr)
AU (1) AU2001238288A1 (fr)
WO (1) WO2001060358A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
HUE039709T2 (hu) * 2002-05-28 2019-01-28 Astrazeneca Ab Helyileg alkalmazandó gyógyászati készítmény
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
MX2010010073A (es) * 2008-03-14 2010-10-04 Otsuka Pharma Co Ltd Inhibidor de la metaloproteasa de matriz-2 y/o de la metaloproteasa de matriz-9.
US11179384B2 (en) 2016-08-26 2021-11-23 Takeda Gmbh Treatment of nonalcoholic fatty liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301943A (es) * 1992-04-02 1994-08-31 Smithkline Beecham Corp Compuestos.

Also Published As

Publication number Publication date
EP1261331A4 (fr) 2005-01-05
EP1261331A1 (fr) 2002-12-04
JP2004502643A (ja) 2004-01-29
WO2001060358A1 (fr) 2001-08-23

Similar Documents

Publication Publication Date Title
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002232919A1 (en) Method for treating fibrotic diseases or other indications
AU2002215125A1 (en) Well treatment method
AU2002243231A1 (en) Method of treating autoimmune diseases
AU2002219945A1 (en) Composition and method for treating snoring
AU2001288271A1 (en) Methods for treating inflammatory diseases
AUPQ533700A0 (en) Soil treatment method
AU2001286983A1 (en) Method of treatment
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
AU2001240046A1 (en) Method of treating skin conditions
AU2001232263A1 (en) Method of treating seeds
AU2001233932A1 (en) Method and composition
HUP0203152A3 (en) Method and compositions for treating pulmonary diseases
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AU2001238179A1 (en) Method and compositions for treating hepatocellular cancer
AU2001262177A1 (en) Method of treatment
AU2002239775A1 (en) Chemical-library composition and method
AU2001274552A1 (en) Method of fundamentally treating common cold
AU4598400A (en) Method of treatment
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU2001253560A1 (en) Methods of treatment
AU2001249194A1 (en) Immunokine composition and method